$31.03
-29.86% past month
Notable price movement
Oct 26, 2026
$30.76-1.63%
IonQ closed down 1.63%, while comparable listed companies in computer integrated systems design rose 0.93% on average . Three of the six fell and three rose, so the cohort was mixed to slightly higher . The decline was therefore not shared by the group on average .
Oct 23, 2026
$31.27+0.35%
Oct 22, 2026
$31.16-3.47%
IonQ fell 3.47% while comparable listed companies in computer integrated systems design rose 2.22% on average, with 4 of 6 rising . The move was therefore not shared by the cohort. 24/7 Wall St wrote that two October deals had turned IonQ into a dilution story and that the stock was down 24% in a month .
Oct 21, 2026
$32.28+3.26%
IonQ rose 3.26%, while comparable listed companies in computer integrated systems design moved up 0.74% on average, with 3 of 6 rising . The gain was larger than the cohort's. Volume was 0.6x the trailing 20-session average .
Oct 20, 2026
$31.26+1.56%
IonQ rose 1.56% while comparable listed companies in computer integrated systems design moved +1.72% on average, with 5 of 6 rising . The move was broadly in line with the cohort.
Oct 19, 2026
$30.78-1.60%
IonQ fell 1.60%, while comparable listed companies in computer integrated systems design rose 0.79% on average, with 5 of 6 higher . The decline was not shared by the cohort.
Oct 16, 2026
$31.28-8.94%
IonQ fell 8.94%, while comparable listed companies in computer integrated systems design moved -3.23% on average, with 4 of 6 falling . The decline was therefore steeper than the cohort's. The Motley Fool reported that investors were concerned about increasing dilution as management made another acquisition . Seeking Alpha published a piece headlined 'Another Crushing Stock Offering' .
Closing prices for IONQ. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Recent news
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.